1254036-77-5 (2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole hydrochloride,2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole hydrochloride)

CAS号:
1254036-77-5
中文名称:
2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole hydrochloride
英文名称:
2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole hydrochloride
分子式:
C26H29ClN6O
分子量:
477.001064062119

2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole hydrochloride(1254036-77-5)名称与标识符

名称

中文别名:
6-(1H-吲哚-4-基)-4-[5-[[4-(1-甲基乙基)-1-哌嗪基]甲基]-2-恶唑基]-1H-吲唑盐酸盐;
英文别名:
2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole hydrochloride;GSK-2269557;6-(1H-indol-4-yl)-4-{5-[(4-isopropylpiperazin-1-yl)methyl]-1,3-oxazol-2-yl}-2H-indazole hydrochloride;BCP28624;SB11336;UNII-II4WQU7U3O;SCHEMBL111259;6-(1H-Indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hydrochloride;CHEMBL5314409;HY-19535;1254036-77-5 (HCl);2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazolehydrochloride;Q27895516;II4WQU7U3O;DS-017360;GSK-2269557; GSK 2269557; GSK2269557;Nemiralisib hydrochloride;2-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-5-[(4-propan-2-ylpiperazin-1-yl)methyl]-1,3-oxazole;hydrochloride;CS-0015634;EX-A993;AC-36100;GSK2269557;1254036-77-5;Nemiralisib (hydrochloride);1H-Indazole, 6-(1H-indol-4-yl)-4-(5-((4-(1-methylethyl)-1-piperazinyl)methyl)-2-oxazolyl)-, hydrochloride (1:1);GECUEJGEJLAXQA-UHFFFAOYSA-N;1h-indazole, 6-(1h-indol-4-yl)-4-[5-[[4-(1-methylethyl)-1-piperazinyl]methyl]-2-oxazolyl]-, hydrochloride (1:1);Nemiralisib HCl;

标识符

MDL:
MFCD27956958
InChIKey:
GECUEJGEJLAXQA-UHFFFAOYSA-N
Inchi:
1S/C26H28N6O.ClH/c1-17(2)32-10-8-31(9-11-32)16-19-14-28-26(33-19)22-12-18(13-25-23(22)15-29-30-25)20-4-3-5-24-21(20)6-7-27-24;/h3-7,12-15,17,27H,8-11,16H2,1-2H3,(H,29,30);1H
SMILES:
Cl.O1C(C2=CC(=CC3=C2C=NN3)C2=CC=CC3=C2C=CN3)=NC=C1CN1CCN(C(C)C)CC1

2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole hydrochloride(1254036-77-5)物化性质

计算特性

  • 精确分子量 : 476.2091373g/mol
  • 氢键供体数量 : 2
  • 氢键受体数量 : 7
  • 可旋转化学键数量 : 5
  • 同位素质量 : 476.2091373g/mol
  • 重原子数量 : 34
  • 复杂度 : 655
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 2
  • 拓扑分子极性表面积 : 77Ų

2-(6-(1H-Indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole hydrochloride(1254036-77-5)推荐厂家 更多厂家(7)